Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Comparing Molecules Linked to Loose Lens Support in Angle-Closure Glaucoma

Compares molecules in people with angle-closure glaucoma who have loose lens support and those without.

Plain-language title generated from the registry record
Registry title: The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

Key facts

Where
Wuhan, ChinaSee the site

Where in China

  • Zhongnan Hospital of Wuhan UniversityWuhan, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Zhongnan Hospital
Trial code
NCT07539675
Record updated
20 April 2026
Original description
Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.Read full original descriptionShow less

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.

Inclusion: Clinically diagnosed with primary angle-closure glaucoma (PACG); Aged ≥ 50 years, no gender restriction; Case Group A: Undergoing glaucoma surgery with intraoperatively confirmed significant zonular laxity; Case Group B: Undergoing glaucoma surgery with intraoperatively confirmed normal zonular morphology; Control group: age- and sex-matched with case groups; clinically diagnosed with age-related cataract; normal anterior chamber depth and angle; no history or signs of glaucoma; undergoing cataract surgery.

Exclusion: History of previous intraocular surgery; Long-term use of medications affecting connective tissue metabolism; Systemic diseases that can cause abnormal ocular zonules; Other severe ocular diseases; Secondary glaucoma.

ClinicalTrials.gov NCT07539675